Retinal Vein Occlusion
Showing NaN - NaN of 7
Macular Edema, Retinal Vein Occlusion Trial in Worldwide (KSI-301, Aflibercept, Sham Procedure)
Active, not recruiting
- Macular Edema
- Retinal Vein Occlusion
- KSI-301
- +2 more
-
Phoenix, Arizona
- +140 more
Jul 20, 2022
Retinal Vein Occlusion, Macula Edema Trial in United States (TLC399 (ProDex))
Completed
- Retinal Vein Occlusion
- Macula Edema
- TLC399 (ProDex)
-
Phoenix, Arizona
- +19 more
Nov 24, 2021
Macular Edema, Retinal Vein Occlusion Trial in Worldwide (suprachoroidal CLS-TA, suprachoroidal sham, Lucentis or Avastin)
Terminated
- Macular Edema
- Retinal Vein Occlusion
- suprachoroidal CLS-TA
- +2 more
-
Phoenix, Arizona
- +91 more
Apr 22, 2021
Retinal Vein Occlusion, Diabetic Macular Edema Trial in Beverly Hills, Boston (KPI-121 0.25% Ophthalmic Suspension, KPI-121 1.0%
Completed
- Retinal Vein Occlusion
- Diabetic Macular Edema
- KPI-121 0.25% Ophthalmic Suspension
- KPI-121 1.0% Ophthalmic Suspension
-
Beverly Hills, California
- +1 more
Dec 9, 2020
Macular Edema, Retinal Vein Occlusion Trial in Lexington, Boston, Cleveland (Fluocinolone Acetonide)
Terminated
- Macular Edema
- Retinal Vein Occlusion
- Fluocinolone Acetonide
-
Lexington, Kentucky
- +2 more
May 8, 2015
Retinal Vein Occlusion Trial in United States (ranibizumab, Peripheral Laser)
Completed
- Retinal Vein Occlusion
- ranibizumab
- Peripheral Laser
-
Beverly Hills, California
- +5 more
Nov 27, 2013
Retinal Vein Occlusion Trial in United States (pegaptanib sodium)
Completed
- Retinal Vein Occlusion
- pegaptanib sodium
-
Tucson, Arizona
- +34 more
Jan 17, 2007